01/11/2024  08:16:06 Var. +1.05 Volume Denaro17:35:26 Lettera17:35:26 Capitalizzazione di mercato Dividend Y. Rapporto P/E
151.75EUR +0.70% 0
Fatturato: 0.00
-Quantità in denaro: - -Quantità in lettera: - 20.01 bill.EUR 1.42% 23.86

Descrizione business

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Belén Garijo
Consiglio di amministrazione
Marcus Kuhnert, Dr. Kai Beckmann, Matthias Heinzel, Peter Guenter
Consiglio di sorveglianza
Dr. Wolfgang Büchele, Sascha Held, Alexander Putz, Anne Lange, Christian Raabe, Daniel Thelen, Dietmar Oeter, Gabriele Eismann, Helene von Roeder, Helga Rübsamen-Schaeff, Jürgen Glaser, Michael Kleinemeier, Peter Emanuel Merck, Renate Koehler, Simon Thelen, Birgit Biermann
 

Dati aziendali

Name: Merck KGaA
Indirizzo: Frankfurter Str. 250,D-64293 Darmstadt
Telefono: +49-6151-72-0
Fax: +49-6151-72-2000
E-mail: service@merckgroup.com
Internet: www.merck.de
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 66.28%
Data dell'IPO: 20/10/1995

Rapporti con gli investitori

Name: Constantin Fest
IR telefono: +49-6151-72-3321
IR Fax: +49-6151-72-91-3321
IR e-mail: investor.relations@m...oup.com investor.relations@merckgroup.com

Company calendar

CW 46 | 14/11/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
73.64%
BlackRock, Inc.
 
7.43%
Massachusetts Financial Services Company
 
5.06%
Sun Life Financial Inc.
 
4.91%
FMR LLC
 
3.02%
Amundi S.A.
 
2.99%
DWS Investment GmbH
 
2.95%